TSLP and neoplasm: Importantly, TSLP treatment failed to inhibit TSLPRkd-SW1116-derived tumor growth (Figure 6B-6C), which was accompanied by similar tumor necrotic areas and apoptotic responses to those in control group without TSLP treatment (Figure 6D-6F).